VEGFA and Kaposi's sarcoma: For instance, Stallone et al. [30], just like other authors [31, 32], demonstrated a potential role of sirolimus in inhibiting the progression of KS in kidney transplant recipients, postulated to occur through the down-regulation of vascular endothelial growth factor (VEGF) and inhibition of tumor angiogenesis [30, 33].